CCL8 and cervical cancer: These findings suggest that the NF-κB pathway is responsible for hypoxia-induced ZEB1-mediated TAM infiltration, and targeting ZEB1-CCL8-NF-κB axis could be a promising strategy for the cervical cancer treatment [147].